2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
9
Lung Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Prostatic Neoplasms
3
Barrett Esophagus
3
Stomach Neoplasms
2
Recurrence
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Multiple Pulmonary Nodules
2
Melanoma
2
Glioma
2
Colorectal Neoplasms
2
Adenocarcinoma of Lung
2
Triple Negative Breast Neoplasms
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Spinal Fractures
1
Solitary Pulmonary Nodule
1
Smoking Cessation
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Phyllodes Tumor
1
Osteoporosis
1
Nevus
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Lymphoma, Follicular
1
Lung Diseases
1
Interventions
3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol
6
pimonidazole
4
fluoroazomycin arabinoside
4
TH 302
4
Radiotherapy
4
Propofol
3
Injections
3
Positron Emission Tomography Computed Tomography
2
Drug Therapy
2
Blood Specimen Collection
2
Bacterial Load
2
pomalidomide
1
pembrolizumab
1
inositol trispyrophosphate
1
gadobutrol
1
fluoromisonidazole
1
fludarabine
1
alovudine
1
Tirapazamine
1
Thoracotomy
1
Thoracic Surgery, Video-Assisted
1
Temozolomide
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Sevoflurane
1
Saline Solution
1
Pancreaticoduodenectomy
1
Paclitaxel
1
Oxygen
1
Nitroglycerin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hypoxia
×
Diagnostic Imaging
×
Clear all
NCT04001023
2019-08-07
OVANOX
Turku University Hospital
Phase NA
Unknown
40 enrolled